Companion Animal Diagnostic Services Market Size & Growth Forecast 2027–2036, By Segments (Type, Animal Type, Testing Category), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Companion Animal Diagnostic Services Market size was over USD 10.33 billion in 2026 and is likely to grow at a 7.13% CAGR between 2027 and 2036, crossing USD 20.57 billion by 2036. The industry revenue for 2027 is calculated at USD 10.95 billion.
Get more details on this report
Request Free Sample ReportCompanion Animal Diagnostic Services Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 40.55% of the market in 2026, supported by advanced veterinary infrastructure, high diagnostic adoption, and routine use of testing for preventive and clinical care.
- Asia Pacific is projected to expand at an 8.59% CAGR as veterinary capacity grows, pet ownership increases, and diagnostic testing becomes more integrated into routine animal healthcare.
Segment Momentum
- Point-of-Care services held a 61.88% share in 2026 because rapid in-clinic results support immediate treatment decisions, improve workflow efficiency, and meet owner expectations for timely diagnostics.
- Cats are the fastest-growing segment as veterinary providers and owners place greater emphasis on feline-specific health monitoring and earlier diagnostic evaluation for subtle health conditions.
Market Expansion Drivers
- Rising pet ownership and humanization increasing demand for advanced veterinary diagnostic services.
- Advancements in imaging and point-of-care diagnostics improving veterinary disease detection capabilities.
- Expanding pet insurance adoption encouraging utilization of preventive and specialized animal diagnostics.
Leading Market Participants
- Top companies in the companion animal diagnostic services market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Mars Incorporated (United States), SYNLAB International GmbH (Germany), IVC Evidensia (United Kingdom), CVS Group plc (United Kingdom), Greencross Limited (Australia), Embark Veterinary, Inc. (United States), Nationwide Laboratories Ltd. (United Kingdom), The Animal Medical Center (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 10.33 billion
- 2027 Estimated Market Size: USD 10.95 billion.
- Projected Market Size: USD 20.57 billion by 2036
- Growth Forecast: 7.13% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Point-of-Care (POC) (Type) | Dogs (Animal Type) | Clinical Chemistry (Testing Category)
- Emerging Opportunity Segment: Laboratory-based (Type) | Cats (Animal Type) | Cytopathology (Testing Category)
Market Growth Drivers and Industry Trends
Rising pet ownership and humanization increasing demand for advanced veterinary diagnostic services
The expansion of pet ownership and growing emotional investment in companion animals are driving the companion animal diagnostic services market as owners become more willing to pursue comprehensive veterinary care. Pet humanization has increased expectations for timely disease detection, routine health screening, and specialized medical assessment comparable with approaches used in human healthcare. Veterinary diagnostic services support these needs by enabling clinicians to investigate symptoms, monitor chronic conditions, and make more informed treatment decisions for companion animals.
Advancements in imaging and point-of-care diagnostics improving veterinary disease detection capabilities
Technological progress in diagnostic imaging and point-of-care testing is enhancing the companion animal diagnostic services market by improving the speed and quality of veterinary assessments. Advanced imaging can provide more detailed information about internal structures and disease conditions, while point-of-care technologies allow certain tests to be performed closer to the time and location of clinical consultation. Faster access to diagnostic information can support earlier intervention and more targeted treatment decisions across veterinary practices.
Expanding pet insurance adoption encouraging utilization of preventive and specialized animal diagnostics
The increasing availability and adoption of pet insurance are supporting the companion animal diagnostic services market by reducing financial barriers associated with veterinary testing and specialized care. Insurance coverage can make diagnostic procedures more accessible when animals require advanced examinations, laboratory testing, imaging, or ongoing disease monitoring. As owners become more comfortable using covered veterinary services, insurance can also encourage greater engagement with preventive healthcare and routine diagnostic assessments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising pet ownership and humanization increasing demand for advanced veterinary diagnostic services | 1.90% | Moderate | North America, Europe | High | Near Term |
| Advancements in imaging and point-of-care diagnostics improving veterinary disease detection capabilities | 1.70% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding pet insurance adoption encouraging utilization of preventive and specialized animal diagnostics | 1.50% | Low | Europe, North America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the companion animal diagnostic services market, North America held the largest share at 40.55% in 2026. The region benefits from advanced veterinary healthcare infrastructure, widespread adoption of diagnostic technologies, and increasing willingness among pet owners to invest in sophisticated medical care. Greater emphasis on early disease detection, routine health screening, and personalized veterinary treatment is encouraging broader use of laboratory testing and diagnostic imaging. The growing humanization of pets and the availability of specialized veterinary services are further strengthening demand for comprehensive diagnostic capabilities.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is poised for the fastest growth as pet ownership increases and veterinary healthcare systems continue to modernize. Rising awareness of companion animal health is encouraging owners to pursue professional diagnosis and preventive care rather than relying solely on treatment after symptoms emerge. Expansion of veterinary facilities, improving access to diagnostic technologies, and greater availability of specialized animal healthcare services are supporting market development. Increasing consumer focus on pet well-being is also creating stronger demand for timely and accurate diagnostic services across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Veterinary TestingGermany prioritizes high-quality companion animal diagnostic services through modern laboratory infrastructure and evidence-based veterinary practice. Demand continues to grow for accurate diagnostic testing that improves clinical decision-making and long-term animal health management.
France 🇫🇷
Comprehensive Veterinary ScreeningFrance continues strengthening companion animal diagnostic services by expanding preventive screening and specialized laboratory capabilities. Veterinary professionals are adopting broader diagnostic portfolios to improve disease management and support informed treatment decisions.
Italy 🇮🇹
Accessible Diagnostic NetworksItaly is enhancing companion animal diagnostic services through wider access to veterinary laboratories and improved diagnostic technologies. Growing emphasis on timely testing supports better clinical management while addressing increasing expectations for high-quality companion animal healthcare.
Japan 🇯🇵
Preventive Care DiagnosticsJapan places strong emphasis on routine health assessments and early disease detection within the companion animal diagnostic services market. Veterinary clinics increasingly incorporate advanced diagnostic technologies to support preventive care and improve treatment outcomes.
South Korea 🇰🇷
Digital Veterinary ServicesSouth Korea is expanding companion animal diagnostic services through investments in digital veterinary workflows and modern diagnostic equipment. Clinics increasingly integrate rapid testing and imaging technologies to deliver efficient and accurate clinical evaluations.
United States 🇺🇸
Advanced Clinical DiagnosticsThe U.S. companion animal diagnostic services market is characterized by increasing use of advanced laboratory testing, imaging, and preventive screening. Veterinary providers continue expanding diagnostic capabilities to support earlier disease detection and more personalized treatment planning for companion animals.
Segment Leadership and Growth Trends
Companion Animal Diagnostic Services Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Point-of-Care (POC) (Largest Segment) vs Laboratory-based (Fastest-Growing Segment)
Holding a 61.88% share in 2026, the point-of-care (POC) segment was the largest in the companion animal diagnostic services market, supported by the need for rapid clinical decision-making and convenient testing within veterinary settings. Point-of-care diagnostics allow veterinarians to obtain timely results during consultations, enabling faster diagnosis and treatment initiation while reducing dependence on external laboratory processing. Increasing veterinary caseloads, greater emphasis on preventive care, and rising demand for efficient diagnostic workflows are strengthening the role of POC testing in routine and urgent animal healthcare.
Laboratory-based diagnostic services are gaining traction as veterinary medicine increasingly adopts more comprehensive and specialized testing approaches. These services can support detailed analysis for complex conditions that require broader diagnostic capabilities, including advanced pathology, molecular testing, and confirmatory evaluations. Growing awareness of early disease detection and the increasing use of diagnostics to guide precise treatment decisions are encouraging veterinary providers to utilize laboratory-based testing alongside point-of-care methods.
Animal Type Segment Analysis: Dogs (Largest Segment) vs Cats (Fastest-Growing Segment)
The dogs segment accounted for a 57.42% share of the companion animal diagnostic services market in 2026, underpinned by the extensive use of diagnostic testing for routine health assessments, infectious diseases, chronic conditions, and age-related disorders. Strong demand for canine veterinary care, combined with increasing owner awareness of preventive health screening, supports consistent utilization of diagnostic services. Greater willingness to pursue early detection and ongoing disease monitoring is also encouraging veterinarians and pet owners to incorporate diagnostic testing more regularly into canine healthcare.
Meanwhile, the cats segment is experiencing faster expansion as feline healthcare becomes increasingly focused on preventive monitoring and early diagnosis. Cat owners are showing greater interest in identifying health conditions before they become severe, particularly as awareness of chronic and age-related feline diseases improves. Advances in veterinary diagnostics and the increasing availability of specialized testing are further improving the ability to identify conditions in cats, supporting broader utilization of diagnostic services across feline populations.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Point-of-Care (POC), Laboratory-based | Point-of-Care (POC) | Laboratory-based |
| Animal Type | Dogs, Cats, Horses, Others | Dogs | Cats |
| Testing Category | Clinical Chemistry, Microbiology, Parasitology, Histopathology, Cytopathology, Hematology, Immunology & Serology, Imaging, Molecular Diagnostics, Others | Clinical Chemistry | Cytopathology |
Competitive Landscape and Market Positioning
Leading companies in the companion animal diagnostic services market:
1. IDEXX Laboratories Inc. (United States)
2. Zoetis Inc. (United States)
3. Mars Incorporated (United States)
4. SYNLAB International GmbH (Germany)
5. IVC Evidensia (United Kingdom)
6. CVS Group plc (United Kingdom)
7. Greencross Limited (Australia)
8. Embark Veterinary Inc. (United States)
9. Nationwide Laboratories Ltd. (United Kingdom)
10. The Animal Medical Center (United States)
The companion animal diagnostic services market is evolving through growing adoption of advanced diagnostic imaging, molecular testing, and AI-supported veterinary analysis tools. Service providers are enhancing digital healthcare integration and expanding laboratory capabilities to improve diagnostic accuracy and treatment planning. Rising pet healthcare expenditure and preventive care awareness are fueling development in the companion animal diagnostic services market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories Inc. (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| Mars Incorporated (United States) | |||||||
| SYNLAB International GmbH (Germany) | |||||||
| IVC Evidensia (United Kingdom) | |||||||
| CVS Group plc (United Kingdom) | |||||||
| Greencross Limited (Australia) | |||||||
| Embark Veterinary Inc. (United States) | |||||||
| Nationwide Laboratories Ltd. (United Kingdom) | |||||||
| The Animal Medical Center (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Zoetis Inc. | Sep-24 | Launched Vetscan OptiCell, an AI-powered cartridge-based hematology analyzer designed to provide cost- and space-efficient Complete Blood Count (CBC) analysis at the point of care. |
| EKF Diagnostics | Jul-24 | Launched the Biosen C-Line benchtop glucose and lactate analyzer, featuring a touchscreen and advanced connectivity via EKF Link for clinical and sports training settings. |
| MiDOG Animal Diagnostics | Feb-24 | Introduced an advanced All-in-One Diagnostic Test using molecular-based diagnostics to rapidly detect bacterial and fungal infections alongside antibiotic resistance. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Companion Animal Diagnostic Services Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disease Indication | Infectious Diseases, Chronic Diseases, Parasitic Diseases, Metabolic Disorders, Cancer, Reproductive Disorders |
| Care Setting | General Veterinary Practices, Specialty Veterinary Hospitals, Emergency & Critical Care Centers, Veterinary Referral Centers |
| Payment Source | Out-of-Pocket Payments, Pet Insurance, Veterinary Practice-Financed Services, Institutional/Third-Party Payments |
Companion Animal Diagnostic Services Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Veterinary Network Expansion Opportunity Assessment |
|
| Diagnostic Test Utilization Benchmarking |
|
| Preventive Care and Wellness Screening Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchHow much revenue does the companion animal diagnostic services market generate?
How much is the companion animal diagnostic services industry expected to grow by 2036?
How is pet humanization reshaping demand in the companion animal diagnostic services market?
Which operational trends are accelerating adoption of companion animal diagnostic services?
Why does Point-of-Care (POC) dominate the companion animal diagnostic services market?
Which animal type is growing fastest in the companion animal diagnostic services market?
Why does North America dominate the companion animal diagnostic services market?
What is accelerating growth in Asia Pacific's companion animal diagnostic services market?
What are the prominent companies operating in the companion animal diagnostic services landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization